32,421 reports of this reaction
12.2% of all EVOLOCUMAB reports
#1 most reported adverse reaction
DEVICE DIFFICULT TO USE is the #1 most commonly reported adverse reaction for EVOLOCUMAB, manufactured by Amgen USA Inc.. There are 32,421 FDA adverse event reports linking EVOLOCUMAB to DEVICE DIFFICULT TO USE. This represents approximately 12.2% of all 266,603 adverse event reports for this drug.
Patients taking EVOLOCUMAB who experience device difficult to use should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEVICE DIFFICULT TO USE is a frequently reported adverse event for EVOLOCUMAB, accounting for a significant proportion of all reports.
In addition to device difficult to use, the following adverse reactions have been reported for EVOLOCUMAB:
The following drugs have also been linked to device difficult to use in FDA adverse event reports:
DEVICE DIFFICULT TO USE has been reported as an adverse event in 32,421 FDA reports for EVOLOCUMAB. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEVICE DIFFICULT TO USE accounts for approximately 12.2% of all adverse event reports for EVOLOCUMAB, making it one of the most commonly reported side effect.
If you experience device difficult to use while taking EVOLOCUMAB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.